Centene’s Q1 profit surged past $1B, but its forecast took a step back


The region's largest publicly traded company adjusted its earnings forecast for next year as it looks to recalibrate a core part of its business.

Previous ProPharma relocates Overland Park headquarters to North Carolina
Next Biogen's ALS drug granted accelerated approval by the FDA